98%
921
2 minutes
20
Genome integrity requires replication to be completed before chromosome segregation. The DNA-replication checkpoint (DRC) contributes to this coordination by inhibiting CDK1, which delays mitotic onset. Under-replication of common fragile sites (CFSs), however, escapes surveillance, resulting in mitotic chromosome breaks. Here we asked whether loose DRC activation induced by modest stresses commonly used to destabilize CFSs could explain this leakage. We found that tightening DRC activation or CDK1 inhibition stabilizes CFSs in human cells. Repli-Seq and molecular combing analyses showed a burst of replication initiations implemented in mid S-phase across a subset of late-replicating sequences, including CFSs, while the bulk genome was unaffected. CFS rescue and extra-initiations required CDC6 and CDT1 availability in S-phase, implying that CDK1 inhibition permits mistimed origin licensing and firing. In addition to delaying mitotic onset, tight DRC activation therefore supports replication completion of late origin-poor domains at risk of under-replication, two complementary roles preserving genome stability.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1038/s41594-023-00949-1 | DOI Listing |
Acta Parasitol
September 2025
Région du Centre, Université Joseph Ki-Zerbo, Rue Thomas Sankara, O3 BP 7021, Ouagadougou, Burkina Faso.
Introduction: The objective of the World Health Organization is to achieve the interruption of human African trypanosomiasis (HAT) transmission by 2030.
Methods: This review aims to update knowledge on HAT, through a synthesis on the epidemiology, diagnostic tools and drugs of HAT.
Results: From 1960 to 2024 approximately 132,063 cases of HAT have been reported across Africa.
Glob Health Action
December 2025
School of Public Health, University of Lubumbashi, Lubumbashi, Democratic Republic of Congo.
Background: The WHO recommends the Person-Centred Care approach, based on the biopsychosocial (BPS) model with community participation, to streamline the management of chronic diseases in Primary Health Care (PHC) activities and reduce their growing burden, even in Africa. The Democratic Republic of Congo's (DRC) experience of community participation in implementing the BPS model for chronic diseases has been little explored.
Objective: To describe community ownership of the biopsychosocial model of chronic disease care in PHC facilities in South Kivu province, DRC.
Pan Afr Med J
August 2025
Université Evangélique en Afrique (UEA), Department of Obstetrics and Gynecology, Panzi General Referral Hospital, Bukavu, The Democratic Republic of Congo.
Introduction: pelvic organ prolapse, a common condition, is a real public health problem in developing countries. Its anamnestic and clinical features may present particularities in these environments. The objective of this study was to assess when women present for treatment and the reasons for delay in seeking care.
View Article and Find Full Text PDFGlob Health Action
December 2025
Department of Women and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Enabling civil society organizations (CSOs) in sub-Saharan Africa to develop research ensures equitable scholarly representation and addresses local problems in sexual and reproductive health. To this end, a transnational research collaboration was formed to evaluate abortion services and develop the research capacity of two CSOs in the Democratic Republic of Congo (DRC). The team included Karolinska Institutet, Partners for Reproductive Justice (IPAS) and the National Midwives' Association (SCOSAF).
View Article and Find Full Text PDFTrials
August 2025
Department II of Internal Medicine, Infectious Diseases, Goethe University Frankfurt, University Hospital Frankfurt, Frankfurt am Main, Germany.
Background: The majority of patients recovers from severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) coronavirus disease 2019 (COVID-19) without obvious sequelae, but a significant proportion suffers long-term consequences which have been termed post COVID syndrome (PCS). Despite a wide range of considerations on treatment options in PCS and a significant number of trials initiated, only very few results from randomized controlled trials are currently available. In conclusion, there is an evident medical need to identify treatments for patients with PCS.
View Article and Find Full Text PDF